Skip to content
Screener

Cardiol Therapeutics CRDL Q2 2026 earnings

Reported August 13, 2026 · Before market open

EPS-$0.04Beat by $0.05
EPS estimate-$0.09

Next report

Date not yet announced

FAQ

When did Cardiol Therapeutics report Q2 2026 earnings?
Cardiol Therapeutics (CRDL) reported Q2 2026 earnings on August 13, 2026 before market open.
What were Cardiol Therapeutics's Q2 2026 revenue and EPS?
Cardiol Therapeutics reported eps of $-0.04 for Q2 2026.
Did Cardiol Therapeutics beat estimates in Q2 2026?
EPS beat the consensus estimate of $-0.09 by $0.05.
How did Cardiol Therapeutics's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 42.9% from $-0.07.